Webcast CME

Biologic Therapies VII: Precision Medicine in the Biologic Era


Cases With the Masters:
Clinical Challenges in PsA and SpA

Print this Content

Release Date:   June 7, 2017
Expiration Date:   June 7, 2019

Estimated Time of Completion:   30 minutes

Description

Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.

Cases With the Masters: Clinical Challenges in PsA and SpA will review several cases identifying recommendations for assessment, monitoring, and treatment of PsA as well as identifying diagnosis and treatment for patients with SpA.

Learning Objectives

  1. Evaluate initial diagnosis and treatment of psoriatic arthritis using the GRAPPA and EULAR guidelines.
  2. Highlight management issues of ongoing disease activity including enthesitis and changing treatment options in an established patient with psoriatic arthritis.
  3. Establish diagnosis of spondyloarthropathy and management of comborbity such as colitis in patients with back pain and GI symptoms.

Target Audience

The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Directors and Faculty

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Dafna D. Gladman, MD, FRCPC
Director, Psoriatic Arthritis Program
University Health Network
Centre for Prognosis Studies in the Rheumatic Diseases
Toronto Western Hospital
Toronto, Canada

Philip Mease, MD
Director, Rheumatology Research
Swedish Medical Center
Clinical Professor, University of Washington
School of Medicine
Seattle, WA

Christopher Ritchlin, MD, MPH
Professor of Medicine
Allergy, Immunology and Rheumatology Division
University of Rochester Medical Center
Rochester, NY

Michael H. Weisman, MD
Cedars-Sinai Chair in Rheumatology
Director, Division of Rheumatology
Professor of Medicine
Cedars-Sinai Medical Center
Distinguished Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:


Leonard H. Calabrese, DO
  AbbVie Pharmaceuticals; Bristol Myers Squibb;
Genentech/ Roche; Janssen
Consulting; Teaching and Speaking
  GlaxoSmithKline; Pfizer, Inc.; UCB Consulting
  Crescendo Teaching and Speaking
Dafna D. Gladman, MD
  AbbVie Pharmaceuticals; Bristol-Myers Squibb; Celgene;
Lilly; Janssen; Pfizer, Inc.; Novartis Pharmaceuticals; UCB
Consulting
Grant support
Teaching and Speaking
M. Elaine Husni, MD, MPH
  AbbVie Pharmaceuticals; Genentech; Janssen Consulting
  Amgen; Bristol-Myers Squibb; Genzyme/Sanofi; Lilly, Regeneron Consulting;
Membership on advisory committee or review panels
  Novartis Pharmaceuticals Consulting; Teaching and Speaking
  Pfizer, Inc. Membership on advisory committee or review panels
Philip Mease, MD
  AbbVie Pharmaceuticals; Amgen; Bristol-Myers Squibb Co.;
Celgene Corporation; Crescendo; Genentech Janssen; Lilly;
Pfizer, Inc.; UCB
Consulting
Independent contractor
  (including contracted research)
Teaching and Speaking
  Corrona, LLC; Demira; Sun Pharmaceutical Industries Ltd.;
Zynerba
Consulting
  Merck, Novartis Consulting; Independent contractor (including contracted research)
Christopher Ritchlin, MD, MPH
  AbbVie Pharmaceuticals; Bristol-Myers Squibb Co.; Janssen
Novartis Pharmaceuticals
Consulting
  Amgen Consulting;
Independent contractor (including contracted
   research)
  UCB Consulting; Research support

The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Michael H. Weisman, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb Co.
Celgene Corporation
Crescendo Bioscience, Inc.
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
UCB, Inc.

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the R.J. Fasenmyer Center for Clinical Immunology.